{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:25:16Z","timestamp":1787131516362,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFF1106804"],"award-info":[{"award-number":["2024YFF1106804"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52473161"],"award-info":[{"award-number":["52473161"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52173294"],"award-info":[{"award-number":["52173294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jconrel.2026.114668","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:46:29Z","timestamp":1769618789000},"page":"114668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ultrasmall zwitterion-micelles coupled with anti-checkpoint antibody for overcoming glioma barriers to eliminate stem cells and amplify immunotherapy"],"prefix":"10.1016","volume":"392","author":[{"given":"Ke","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shineng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114668_bb0005","article-title":"Tailoring biomaterials for cancer immunotherapy: emerging trends and future outlook","volume":"29","author":"Wang","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114668_bb0010","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1039\/D0BM00916D","article-title":"Co-inhibition of the TGF-\u03b2 pathway and the PD-L1 checkpoint by pH-responsive clustered nanoparticles for pancreatic cancer microenvironment regulation and anti-tumor immunotherapy","volume":"8","author":"Wang","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.114668_bb0015","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1021\/acs.accounts.0c00486","article-title":"Mechanical immunoengineering of T cells for therapeutic applications","volume":"53","author":"Lei","year":"2020","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2026.114668_bb0020","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nn.4475","article-title":"The role of peripheral immune cells in the CNS in steady state and disease","volume":"20","author":"Prinz","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2026.114668_bb0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.immuni.2021.01.013","article-title":"Astrocyte-immune cell interactions in physiology and pathology","volume":"54","author":"Han","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114668_bb0030","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/nn.4610","article-title":"High-dimensional, single-cell characterization of the brain\u2019s immune compartment","volume":"20","author":"Korin","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jconrel.2026.114668_bb0035","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/cns.13525","article-title":"Functional diversities of myeloid cells in the central nervous system","volume":"26","author":"Zhang","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jconrel.2026.114668_bb0040","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/1381612822666151221150733","article-title":"Evolving drug delivery strategies to overcome the blood brain barrier","volume":"22","author":"Hersh","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2026.114668_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41568-019-0224-7","article-title":"Brain immunology and immunotherapy in brain tumours","volume":"20","author":"Sampson","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114668_bb0050","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.114668_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585616","article-title":"Glioblastoma immune landscape and the potential of new immunotherapies","volume":"11","author":"Daubon","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0060","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2147\/DDDT.S79592","article-title":"Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.jconrel.2026.114668_bb0065","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1039\/C8CS00805A","article-title":"Emerging blood\u2013brain-barrier-crossing nanotechnology for brain cancer theranostics","volume":"48","author":"Tang","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.114668_bb0070","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202407235","article-title":"Open-source throttling of CD8 T cells in brain with low-intensity focused ultrasound-guided sequential delivery of CXCL10, IL-2, and aPD-L1 for glioblastoma immunotherapy","volume":"36","author":"Dong","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114668_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165\u2013166","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114668_bb0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jconrel.2020.05.040","article-title":"Secondary effects on brain physiology caused by focused ultrasound-mediated disruption of the blood-brain barrier","volume":"324","author":"Todd","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114668_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119491","article-title":"Nanomaterial-based blood-brain-barrier (BBB) crossing strategies","volume":"224","author":"Xie","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114668_bb0090","article-title":"Systemic delivery of monoclonal antibodies to the central nervous system for brain tumor therapy","volume":"31","author":"Han","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114668_bb0095","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.86.12.4761","article-title":"Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein","volume":"86","author":"Triguero","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114668_bb0100","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00004647-200109000-00009","article-title":"Recruitment of neutrophils across the blood\u2013brain barrier: the role of E- and P-selectins","volume":"21","author":"Bernardes-Silva","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jconrel.2026.114668_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainres.2009.08.076","article-title":"Modulation of blood-brain barrier permeability by neutrophils: in vitro and in vivo studies","volume":"1298","author":"Joice","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2026.114668_bb0110","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s004010051093","article-title":"Neutrophil infiltration into human gliomas","volume":"98","author":"Fossati","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0115","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1248\/cpb.55.1192","article-title":"Surface modification of RGD-liposomes for selective drug delivery to monocytes\/neutrophils in brain","volume":"55","author":"Qin","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2026.114668_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1023367223575","article-title":"Intracavitary VEGF, bFGF, IL-8, IL-12 levels in primary and recurrent malignant glioma","volume":"62","author":"Salmaggi","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1215\/S1152851704001061","article-title":"The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis","volume":"7","author":"Brat","year":"2005","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jconrel.2026.114668_bb0130","doi-asserted-by":"crossref","first-page":"28220","DOI":"10.1074\/jbc.271.45.28220","article-title":"Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1","volume":"271","author":"Ryuto","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.114668_bb0135","first-page":"4181","article-title":"Tumor necrosis factor alpha induces angiogenic factor up-regulation in malignant glioma cells: a role for RNA stabilization and HuR","volume":"63","author":"Nabors","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114668_bb0140","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nri3399","article-title":"Neutrophil recruitment and function in health and inflammation","volume":"13","author":"Kolaczkowska","year":"2013","journal-title":"Nature Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114895","article-title":"Stealth and pseudo-stealth nanocarriers","volume":"198","author":"Wen","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114668_bb0150","first-page":"1","article-title":"Steric stabilization-independent stealth cloak enables nanoreactors-mediated starvation therapy against refractory cancer","author":"Li","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114668_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/adma.201404059","article-title":"Molecular understanding and design of zwitterionic materials","volume":"27","author":"Shao","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114668_bb0160","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jconrel.2022.02.004","article-title":"Recent advances on next generation of polyzwitterion-based nano-vectors for targeted drug delivery","volume":"343","author":"Qian","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114668_bb0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2023.10.019","article-title":"Super-small zwitterionic micelles enable the improvement of blood-brain barrier crossing for efficient orthotopic glioblastoma combinational therapy","volume":"364","author":"Wang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114668_bb0170","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1007\/s11064-017-2397-3","article-title":"Betaine in the brain: characterization of betaine uptake, its influence on other osmolytes and its potential role in neuroprotection from osmotic stress","volume":"42","author":"Knight","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jconrel.2026.114668_bb0175","article-title":"Fluorination and betaine modification augment the blood\u2013brain barrier-crossing ability of cylindrical polymer brushes","volume":"61","author":"Wang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2026.114668_bb0180","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41467-024-44963-3","article-title":"Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114668_bb0185","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1038\/s41467-021-24902-2","article-title":"Synergistic effect of tumor chemo-immunotherapy induced by leukocyte-hitchhiking thermal-sensitive micelles","volume":"12","author":"Qi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114668_bb0190","doi-asserted-by":"crossref","first-page":"4854","DOI":"10.1111\/jcmm.14356","article-title":"Immunogenic cell death in cancer therapy: present and emerging inducers","volume":"23","author":"Zhou","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2026.114668_bb0195","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.1021\/acsnano.0c03386","article-title":"Translational nanomedicine boosts anti-PD1 therapy to eradicate orthotopic PTEN-negative glioblastoma","volume":"14","author":"Kinoh","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114668_bb0200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0205","doi-asserted-by":"crossref","first-page":"e247","DOI":"10.1016\/j.cllc.2021.09.010","article-title":"Design and rationale for a phase III, double-blind, placebo-controlled study of neoadjuvant durvalumab\u00a0chemotherapy followed by adjuvant durvalumab for the treatment of patients with resectable stages II and III non-small-cell lung cancer: the AEGEAN trial","volume":"23","author":"Heymach","year":"2022","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.jconrel.2026.114668_bb0210","first-page":"522","article-title":"Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study","volume":"7","author":"Oh","year":"2022","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0215","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-020-00966-3","article-title":"Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment","volume":"13","author":"L\u00f3pez De Andr\u00e9s","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0220","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13287-022-02829-9","article-title":"Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy","volume":"13","author":"Dianat-Moghadam","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.jconrel.2026.114668_bb0225","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","article-title":"Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts","volume":"2","author":"Liu","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.jconrel.2026.114668_bb0230","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/acsami.2c20056","article-title":"Robust construction of supersmall zwitterionic micelles based on hyperbranched polycarbonates mediates high tumor accumulation","volume":"15","author":"Zhao","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114668_bb0235","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.actbio.2025.08.013","article-title":"Super-small zwitterionic nitric oxide-donor micelles efficiently scavenge ROS and alleviate inflammation for combined ischemic stroke therapy","volume":"204","author":"Wang","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114668_bb0240","doi-asserted-by":"crossref","first-page":"10169","DOI":"10.1021\/ja302705v","article-title":"Acid-labile traceless click linker for protein transduction","volume":"134","author":"Maier","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114668_bb0245","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1021\/acsnano.1c08120","article-title":"Smart nanomedicine to enable crossing blood\u2013brain barrier delivery of checkpoint blockade antibody for immunotherapy of glioma","volume":"16","author":"Wang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114668_bb0250","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ibd.21403","article-title":"Importance of disrupted intestinal barrier in inflammatory bowel diseases","volume":"17","author":"Salim","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2026.114668_bb0255","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1023\/A:1018823100761","article-title":"Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in vitro by sodium caprate, a constituent of milk fat","volume":"43","author":"S\u00f6derholm","year":"1998","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jconrel.2026.114668_bb0260","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jconrel.2020.04.009","article-title":"\u03b1v\u03b23-targeted liposomal drug delivery system with attenuated immunogenicity enabled by linear pentapeptide for glioma therapy","volume":"322","author":"Li","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114668_bb0265","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bioeng.1.1.241","article-title":"Transport of molecules, particles, and cells in solid tumors","volume":"1","author":"Jain","year":"1999","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114668_bb0270","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","article-title":"Delivering nanomedicine to solid tumors","volume":"7","author":"Jain","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0275","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrm2927","article-title":"Adherens junctions: from molecules to morphogenesis","volume":"11","author":"Harris","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0280","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nnano.2012.45","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","volume":"7","author":"Chauhan","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2014.11.010","article-title":"Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior","volume":"41","author":"Li","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114668_bb0290","doi-asserted-by":"crossref","first-page":"E236","DOI":"10.1038\/ncb1002-e236","article-title":"Motoring around the Golgi","volume":"4","author":"Allan","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114668_bb0295","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.114668_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118005","article-title":"Immune checkpoints in tumor microenvironment and their relevance to the development of cancer stem cells","volume":"256","author":"Khosravi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2026.114668_bb0305","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1158\/1078-0432.CCR-09-2730","article-title":"Immunobiological characterization of cancer stem cells isolated from glioblastoma patients","volume":"16","author":"Tomaso","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114668_bb0310","article-title":"Immunostimulant in situ hydrogel improves synergetic radioimmunotherapy of malignant glioblastoma relapse post-resection","volume":"32","author":"Sun","year":"2022","journal-title":"Adv. Funct. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:34:38Z","timestamp":1787128478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926000696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":62,"alternative-id":["S0168365926000696"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114668","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrasmall zwitterion-micelles coupled with anti-checkpoint antibody for overcoming glioma barriers to eliminate stem cells and amplify immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114668"}}